Copyright
©The Author(s) 2017.
World J Methodol. Mar 26, 2017; 7(1): 16-24
Published online Mar 26, 2017. doi: 10.5662/wjm.v7.i1.16
Published online Mar 26, 2017. doi: 10.5662/wjm.v7.i1.16
Table 1 Description of modified Delphi methodology
| Delphi round 1 | Systematic collection of online clinical score calculators | Identified 176 externally validated online clinical score calculators |
| Delphi round 2 | Survey development | Branching survey logic mapped score calculators to applicable specialties |
| Survey distribution | Academic and community based clinicians |
Table 2 Survey respondent characteristics
| Completion rate | n of Scores | |
| Anesthesia | 2/5 (40%) | 49 |
| Cardiology | 1/1 (100%) | 37 |
| Critical care | 14/23 (61%) | 75 |
| Dermatology | 0/0 | 1 |
| Emergency medicine | 4/6 (67%) | 62 |
| Family medicine | 2/5 (40%) | 107 |
| Gastroenterology | 3/3 (100%) | 17 |
| Hematology | 1/1 (100%) | 5 |
| Infectious disease | 2/2 (100%) | 2 |
| Internal medicine | 14/25 (56%) | 109 |
| Nephrology | 1/1 (100%) | 6 |
| Neurology | 0/1 (0%) | 23 |
| OBGYN | 1/1 (100%) | 1 |
| Oncology | 1/2 (50%) | 5 |
| Orthopedics | 0/0 | 3 |
| Pediatric | 7/13 (54%) | 25 |
| Pulmonology | 4/6 (67%) | 17 |
| Surgery | 2/3 (67%) | 66 |
Table 3 Summary of importance of automation of specified clinical scores ranked by critical care and internal medicine physicians
| Score name | Year of creation | n of variables | Very important | Very important or nice to have |
| Critical care | ||||
| APACHE II | 1985 | 15 | 9/14 (64.3%) | 12/14 (85.7%) |
| SNAP II | 2001 | 9 | 7/11 (63.6%) | 9/11 (81.8%) |
| NRDS scoring system | 1998 | 5 | 7/12 (58.3%) | 10/12 (83.3%) |
| Post-anesthetic recovery score | 1970 | 5 | 7/12 (58.3%) | 9/12 (75%) |
| Rotterdam score | 1997 | 4 | 7/12 (58.3%) | 8/12 (66.7%) |
| SNAP | 1993 | 27 | 7/12 (58.3%) | 9/12 (75%) |
| SNAP-PE | 1993 | 30 | 7/12 (58.3%) | 9/12 (75%) |
| SNAP-PE II | 2001 | 12 | 7/12 (58.3%) | 9/12 (75%) |
| Wells criteria for DVT | 2006 | 9 | 7/12 (58.3%) | 9/12 (75%) |
| Wells criteria for PE | 1998 | 7 | 7/12 (58.3%) | 10/12 (83.3%) |
| PAWS | 2008 | 7 | 6/11 (54.5%) | 8/11 (72.7%) |
| CRIB | 1993 | 5 | 6/12 (50%) | 8/12 (66.7%) |
| CRIB II | 2003 | 5 | 6/12 (50%) | 8/12 (66.7%) |
| MSSS | 2002 | 7 | 6/12 (50%) | 8/12 (66.7%) |
| PELOD score | 1999 | 13 | 3/6 (50%) | 4/6 (66.7%) |
| SAPS II | 1993 | 16 | 5/10 (50%) | 7/10 (70%) |
| TIMI risk index | 2006 | 3 | 5/11 (45.5%) | 8/11 (72.7%) |
| TRISS | 1987 | 9 | 4/9 (44.4%) | 6/9 (66.7%) |
| Children's coma score | 1984 | 3 | 3/7 (42.9%) | 4/7 (57.1%) |
| PRISM score | 1988 | 16 | 3/7 (42.9%) | 5/7 (71.4%) |
| CURB-65 | 2003 | 5 | 5/12 (41.7%) | 8/12 (66.7%) |
| SCORETEN scale | 2000 | 6 | 5/12 (41.7%) | 9/12 (75%) |
| MEWS score | 2006 | 6 | 4/10 (40%) | 6/10 (60%) |
| Rockall score | 2008 | 11 | 3/8 (37.5%) | 5/8 (62.5%) |
| TRIOS score | 2001 | 4 | 3/8 (37.5%) | 5/8 (62.5%) |
| Geneva score for PE | 2006 | 9 | 4/11 (36.4%) | 7/11 (63.6%) |
| Injury Severity Score | 1974 | 6 | 4/11 (36.4%) | 8/11 (72.7%) |
| Lung Injury score | 1988 | 5 | 4/11 (36.4%) | 8/11 (72.7%) |
| MPMII - admission | 1993 | 14 | 4/11 (36.4%) | 6/11 (54.5%) |
| MPMII - 24-48-72 | 1993 | 14 | 4/11 (36.4%) | 6/11 (54.5%) |
| LODS score | 1996 | 12 | 3/9 (33.3%) | 7/9 (77.8%) |
| MEDS score | 2003 | 10 | 3/9 (33.3%) | 6/9 (66.7%) |
| MESS score | 1990 | 5 | 4/12 (33.3%) | 7/12 (58.3%) |
| Parsonnet Score | 1989 | 14 | 4/12 (33.3%) | 7/12 (58.3%) |
| Pediatric coma scale | 1988 | 3 | 2/6 (33.3%) | 3/6 (50%) |
| RAPS | 1987 | 5 | 3/9 (33.3%) | 7/9 (77.8%) |
| Surgical Apgar score | 2007 | 3 | 4/12 (33.3%) | 8/12 (66.7%) |
| ASCOT score | 1990 | 8 | 4/13 (30.8%) | 6/13 (46.2%) |
| MELD score | 2001 | 4 | 4/13 (30.8%) | 12/13 (92.3%) |
| PIM2 | 2003 | 8 | 2/7 (28.6%) | 5/7 (71.4%) |
| SWIFT score | 2008 | 6 | 2/7 (28.6%) | 4/7 (57.1%) |
| Clinical Pulmonary Infection Score | 1991 | 8 | 3/11 (27.3%) | 9/11 (81.8%) |
| MPM-24 h | 1988 | 15 | 3/11 (27.3%) | 6/11 (54.5%) |
| Child-Pugh Score | 1973 | 5 | 3/12 (25%) | 11/12 (91.7%) |
| Decaf score | 2012 | 5 | 2/8 (25%) | 4/8 (50%) |
| ONTARIO score | 1995 | 6 | 2/8 (25%) | 4/8 (50%) |
| AKICS score | 2007 | 8 | 3/13 (23.1%) | 7/13 (53.8%) |
| AVPU scale | 2004 | 4 | 2/9 (22.2%) | 6/9 (66.7%) |
| PERC rule for PE | 2001 | 7 | 2/9 (22.2%) | 6/9 (66.7%) |
| RIETE score | 1988 | 6 | 2/9 (22.2%) | 6/9 (66.7%) |
| BISAP score for pancreatitis mortality | 2008 | 5 | 2/10 (20%) | 4/10 (40%) |
| Bleeding risk score | 2007 | 4 | 2/10 (20%) | 6/10 (60%) |
| Clinical asthma evaluation score | 1972 | 5 | 2/10 (20%) | 6/10 (60%) |
| PIRO score | 2009 | 8 | 2/10 (20%) | 7/10 (70%) |
| ABC score for massive transfusion | 2009 | 4 | 2/11 (18.2%) | 6/11 (54.5%) |
| ACLS score | 1981 | 4 | 2/11 (18.2%) | 7/11 (63.6%) |
| MOD score | 1995 | 7 | 2/11 (18.2%) | 8/11 (72.7%) |
| MPM - admission | 1988 | 10 | 2/11 (18.2%) | 6/11 (54.5%) |
| sPESI | 2010 | 8 | 2/11 (18.2%) | 7/11 (63.6%) |
| ABIC score | 2008 | 4 | 2/12 (16.7%) | 5/12 (41.7%) |
| CRUSADE score | 2009 | 8 | 2/12 (16.7%) | 6/12 (50%) |
| Pediatric trauma score | 1988 | 6 | 1/6 (16.7%) | 2/6 (33.3%) |
| LRINEC Score for Necrotizing STI | 2004 | 5 | 1/8 (12.5%) | 4/8 (50%) |
| Panc 3 score | 2007 | 3 | 1/8 (12.5%) | 3/8 (37.5%) |
| Pancreatitis outcome score | 2007 | 7 | 1/8 (12.5%) | 3/8 (37.5%) |
| TASH score | 2006 | 7 | 1/8 (12.5%) | 4/8 (50%) |
| POSSUM score | 1991 | 18 | 1/9 (11.1%) | 3/9 (33.3%) |
| Revised Trauma score | 1981 | 3 | 1/9 (11.1%) | 5/9 (55.6%) |
| 24 h ICU trauma score | 1992 | 4 | 1/10 (10%) | 7/10 (70%) |
| HIT Expert Probability Score | 2010 | 11 | 1/11 (9.1%) | 6/11 (54.5%) |
| Bronchiectasis severity index | 2014 | 10 | 1/12 (8.3%) | 4/12 (33.3%) |
| Oxygenation index | 2005 | 3 | 1/13 (7.7%) | 7/13 (53.8%) |
| CT severity index | 1990 | 1 | 0/12 (0%) | 6/12 (50%) |
| Glasgow coma scale | 1974 | 3 | 0/13 (0%) | 10/13 (76.9%) |
| SOFA | 2001 | 6 | 0/13 (0%) | 8/13 (61.5%) |
| Internal medicine | ||||
| Wells criteria for DVT | 2006 | 9 | 10/14 (71.4%) | 13/14 (92.9%) |
| Wells criteria for PE | 1998 | 7 | 10/14 (71.4%) | 13/14 (92.9%) |
| CHA2DS2-VASc | 2010 | 7 | 9/14 (64.3%) | 13/14 (92.9%) |
| TIMI risk index | 2006 | 3 | 9/14 (64.3%) | 13/14 (92.9%) |
| TIMI risk score for UA/NSTEMI | 2000 | 7 | 9/14 (64.3%) | 13/14 (92.9%) |
| TIMI risk score for STEMI | 2000 | 9 | 9/14 (64.3%) | 13/14 (92.9%) |
| CURB-65 | 2003 | 5 | 8/14 (57.1%) | 13/14 (92.9%) |
| STESS score | 2008 | 4 | 8/14 (57.1%) | 13/14 (92.9%) |
| Duke criteria for IE | 1994 | 8 | 6/13 (46.2%) | 12/13 (92.3%) |
| PESI | 2006 | 11 | 7/12 (58.3%) | 11/12 (91.7%) |
| Revised cardiac risk index for pre-operative risk | 1999 | 6 | 7/12 (58.3%) | 11/12 (91.7%) |
| SOFA | 2001 | 6 | 6/12 (50%) | 11/12 (91.7%) |
| ABCD2 score | 2006 | 5 | 5/12 (41.7%) | 11/12 (91.7%) |
| Charlson Comorbidity index | 1987 | 1 | 2/12 (16.7%) | 11/12 (91.7%) |
| PERC rule for PE | 2001 | 7 | 5/11 (45.5%) | 10/11 (90.9%) |
| sPESI | 2010 | 8 | 4/11 (36.4%) | 10/11 (90.9%) |
| MOD score | 1995 | 7 | 3/11 (27.3%) | 10/11 (90.9%) |
| MPM - 24 h | 1988 | 15 | 4/10 (40%) | 9/10 (90%) |
| MPM - admission | 1988 | 10 | 3/10 (30%) | 9/10 (90%) |
| MEDS score | 2003 | 10 | 2/10 (20%) | 9/10 (90%) |
| PIRO score | 2009 | 8 | 1/10 (10%) | 9/10 (90%) |
| SAPS II | 1993 | 16 | 4/9 (44.4%) | 8/9 (88.9%) |
| SWIFT score | 2008 | 6 | 2/8 (25%) | 7/8 (87.5%) |
| Panc 3 score | 2007 | 3 | 1/8 (12.5%) | 7/8 (87.5%) |
| APACHE II | 1985 | 15 | 9/14 (64.3%) | 12/14 (85.7%) |
| Parsonnett Score | 1989 | 14 | 8/14 (57.1%) | 12/14 (85.7%) |
| HIT Expert Probability Score | 2010 | 11 | 6/14 (42.9%) | 12/14 (85.7%) |
| Ranson's criteria | 1974 | 11 | 6/14 (42.9%) | 12/14 (85.7%) |
| TRIOS score | 2001 | 4 | 3/7 (42.9%) | 6/7 (85.7%) |
| 4Ts Score | 2006 | 5 | 5/14 (35.7%) | 12/14 (85.7%) |
| Framingham coronary heart disease risk score | 1998 | 7 | 5/14 (35.7%) | 12/14 (85.7%) |
| 30 d PCI readmission risk | 2013 | 10 | 2/7 (28.6%) | 6/7 (85.7%) |
| Glasgow coma scale | 1974 | 3 | 9/13 (69.2%) | 11/13 (84.6%) |
| Modified NIH Stroke Scale | 2001 | 9 | 7/13 (53.9%) | 11/13 (84.6%) |
| King's College Criteria for Acetaminophen Toxicity | 1989 | 6 | 4/12 (33.3%) | 10/12 (83.3%) |
| Glasgow-Blatchford Bleeding score | 2000 | 9 | 3/12 (25%) | 10/12 (83.3%) |
| ATRIA bleeding risk score | 2011 | 6 | 2/12 (16.7%) | 10/12 (83.3%) |
| Glasgow Alcoholic hepatitis score | 2005 | 4 | 5/11 (45.5%) | 9/11 (81.8%) |
| MEWS score | 2006 | 6 | 4/11 (36.4%) | 9/11 (81.8%) |
| Hemorr2hages score | 2006 | 11 | 2/11 (18.2%) | 9/11 (81.8%) |
| Decaf score | 2012 | 5 | 4/10 (40%) | 8/10 (80%) |
| MPMII - admission | 1993 | 14 | 4/10 (40%) | 8/10 (80%) |
| MPMII - 24-48-72 | 1993 | 14 | 4/10 (40%) | 8/10 (80%) |
| Malnutrition universal screening tool (MUST) | 2004 | 3 | 2/10 (20%) | 8/10 (80%) |
| ASTRAL score | 2012 | 6 | 1/10 (10%) | 8/10 (80%) |
| GRACE ACS | 2006 | 12 | 1/10 (10%) | 8/10 (80%) |
| CHADS2 | 2001 | 5 | 7/14 (50%) | 11/14 (78.6%) |
| Multidimensional frailty score | 2014 | 9 | 7/14 (50%) | 11/14 (78.6%) |
| Geneva score for PE | 2006 | 9 | 3/9 (33.3%) | 7/9 (77.8%) |
| Pittsburg knee rules | 1994 | 3 | 3/9 (33.3%) | 7/9 (77.8%) |
| Mayo scoring system for assessment of ulcerative colitis activity | 2005 | 4 | 1/9 (11.1%) | 7/9 (77.8%) |
| 4-yr mortality prognostic index | 2006 | 12 | 1/9 (11.1%) | 7/9 (77.8%) |
| Rockall score | 2008 | 11 | 1/9 (11.1%) | 7/9 (77.8%) |
| SHARF scoring system | 2004 | 9 | 1/9 (11.1%) | 7/9 (77.8%) |
| HAS-BLED | 2010 | 12 | 5/13 (38.5%) | 10/13 (76.9%) |
| ATRIA stroke risk score | 2013 | 7 | 3/12 (25%) | 9/12 (75%) |
| Euroscore | 1999 | 17 | 1/8 (12.5%) | 6/8 (75%) |
| Renal risk score | 2011 | 6 | 1/8 (12.5%) | 6/8 (75%) |
| ROSE risk score | 1996 | 7 | 1/8 (12.5%) | 6/8 (75%) |
| LRINEC Score for Necrotizing STI | 2004 | 5 | 3/11 (27.3%) | 8/11 (72.7%) |
| Bleeding risk score | 2007 | 4 | 2/11 (18.2%) | 8/11 (72.7%) |
| CT severity index | 1990 | 1 | 1/11 (9.1%) | 8/11 (72.7%) |
| SCORETEN scale | 2000 | 6 | 7/14 (50%) | 10/14 (71.4%) |
| REMS | 2004 | 7 | 2/7 (28.6%) | 5/7 (71.4%) |
| Mayo CABG risk of inpatient death after MI | 2007 | 7 | 1/7 (14.3%) | 5/7 (71.4%) |
| Mayo PCI risk of inpatient MACE | 2007 | 7 | 1/7 (14.3%) | 5/7 (71.4%) |
| QMMI score | 2001 | 11 | 1/7 (14.3%) | 5/7 (71.4%) |
| MELD score | 2001 | 4 | 0/14 (0%) | 10/14 (71.4%) |
| Nexus criteria for C-spine imaging | 1970 | 5 | 4/10 (40%) | 7/10 (70%) |
| Birmingham nutritional risk score | 1995 | 7 | 2/10 (20%) | 7/10 (70%) |
| Canadian CT head rule | 2001 | 9 | 2/10 (20%) | 7/10 (70%) |
| ACLS score | 1981 | 4 | 1/10 (10%) | 7/10 (70%) |
| San Francisco syncope rule | 2004 | 5 | 1/10 (10%) | 7/10 (70%) |
| Mannheim peritonitis index | 1993 | 7 | 6/13 (46.2%) | 9/13 (69.2%) |
| HADO score | 2006 | 4 | 3/9 (33.3%) | 6/9 (66.7%) |
| CARE score | 2001 | 3 | 1/9 (11.1%) | 6/9 (66.7%) |
| ICH score | 2001 | 5 | 1/9 (11.1%) | 6/9 (66.7%) |
| Adult appendicitis score | 2014 | 8 | 6/14 (42.9%) | 9/14 (64.3%) |
| IMPACT score | 2008 | 11 | 6/14 (42.9%) | 9/14 (64.3%) |
| CRUSADE score | 2009 | 8 | 4/14 (28.6%) | 9/14 (64.3%) |
| PORT/PSI score | 1997 | 20 | 2/14 (14.3%) | 9/14 (64.3%) |
| CIWA-Ar | 1989 | 10 | 1/14 (7.1%) | 9/14 (64.3%) |
| LODS score | 1996 | 12 | 3/8 (37.5%) | 5/8 (62.5%) |
| OESIL risk score | 2003 | 4 | 2/8 (25%) | 5/8 (62.5%) |
| QRISK2 | 2010 | 14 | 2/8 (25%) | 5/8 (62.5%) |
| Qstroke score | 2013 | 15 | 2/8 (25%) | 5/8 (62.5%) |
| RIETE score | 1988 | 6 | 2/8 (25%) | 5/8 (62.5%) |
| EGSYS score | 2008 | 6 | 1/8 (12.5%) | 5/8 (62.5%) |
| EHMRG | 2012 | 10 | 1/8 (12.5%) | 5/8 (62.5%) |
| FOUR score | 2005 | 4 | 1/8 (12.5%) | 5/8 (62.5%) |
| Pancreatitis outcome score | 2007 | 7 | 1/8 (12.5%) | 5/8 (62.5%) |
| Prostate cancer prevention trial risk calculator | 1993 | 6 | 6/13 (46.2%) | 8/13 (61.5%) |
| Alvarado score for acute appendicitis | 1986 | 8 | 5/13 (38.5%) | 8/13 (61.5%) |
| DRAGON score | 2012 | 6 | 1/10 (10%) | 6/10 (60%) |
| Bronchiectasis severity index | 2014 | 10 | 3/14 (21.4%) | 8/14 (57.1%) |
| New Orleans head CT rule | 2000 | 8 | 1/7 (14.3%) | 4/7 (57.1%) |
| POSSUM score | 1991 | 18 | 1/7 (14.3%) | 4/7 (57.1%) |
| Child-Pugh Score | 1973 | 5 | 0/14 (0%) | 8/14 (57.1%) |
| Lung Injury score | 1988 | 5 | 4/9 (44.4%) | 5/9 (55.6%) |
| AVPU scale | 2004 | 4 | 2/9 (22.2%) | 5/9 (55.6%) |
| Gupta perioperative cardiac risk | 2011 | 5 | 2/9 (22.2%) | 5/9 (55.6%) |
| HEART score | 2008 | 5 | 1/9 (11.1%) | 5/9 (55.6%) |
| IgA nephropathy score | 2006 | 8 | 5/14 (35.7%) | 7/14 (50%) |
| ABIC score | 2008 | 4 | 4/14 (28.6%) | 7/14 (50%) |
| CAMBS score | 1993 | 4 | 4/14 (28.6%) | 7/14 (50%) |
| GAP risk assessment score | 2012 | 4 | 2/8 (25%) | 4/8 (50%) |
| BISAP score for pancreatitis mortality | 2008 | 5 | 2/10 (20%) | 5/10 (50%) |
| ONTARIO score | 1995 | 6 | 1/8 (12.5%) | 4/8 (50%) |
| JAMA kidney failure risk equation | 2011 | 7 | 4/13 (30.8%) | 5/13 (38.5%) |
Table 4 Predictors of desirability of score automation based on number of each variable type in each score
| Automation: Very important/nice to have | OR (95%CI) |
| Critical care | |
| n of variables | 0.68 (0.23, 1.59) |
| Clinical history | 1.36 (0.36, 4.93) |
| Vital sign | 1.40 (0.53, 4.6) |
| Medication | 4.89 (0.10, 237.52) |
| Clinical judgment | 2.33 (0.76, 9.80) |
| Examination | 0.99 (0.36, 3.14) |
| Laboratory value | 1.48 (0.61, 4.41) |
| Charted variable (non-vital) | 2.26 (0.70, 8.93) |
| Demographic value | 0.20 (0.03, 1.00) |
| Another score | 2.07 (0.39, 12.13) |
| Internal medicine | |
| n of variables | 0.64 (0.39, 1.04) |
| Clinical history | 2.34a (1.26, 4.67) |
| Vital sign | 1.88a (1.03, 3.68) |
| Medication | 2.89 (0.37, 63.17) |
| Clinical judgment | 1.41 (0.75, 2.74) |
| Examination | 1.56 (0.88, 2.87) |
| Laboratory value | 1.51 (0.90, 2.62) |
| Charted variable (non-vital) | 2.54 (0.85, 8.70) |
| Demographic value | 0.90 (0.41, 1.97) |
| Another score | 0.89 (0.30, 2.17) |
- Citation: Aakre CA, Dziadzko MA, Herasevich V. Towards automated calculation of evidence-based clinical scores. World J Methodol 2017; 7(1): 16-24
- URL: https://www.wjgnet.com/2222-0682/full/v7/i1/16.htm
- DOI: https://dx.doi.org/10.5662/wjm.v7.i1.16
